Cost-effectiveness analysis of five anti-obesity medications from a US payer ’s perspective

To determine the cost-effectiveness of anti-obesity medications (AOM): tirzepatide, semaglutide, liraglutide, phentermine plus topiramate (PpT), and naltrexone plus bupropion (NpB).

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - March 25, 2023 Category: Nutrition Authors: Ainhoa G ómez Lumbreras, Malinda S Tan, Lorenzo Vila-Zapata, Sabrina Ilham, Jacob C Earl, Daniel C Malone Source Type: research